Page last updated: 2024-10-23

aspirin and Pulmonary Fibrosis

aspirin has been researched along with Pulmonary Fibrosis in 8 studies

Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.

Pulmonary Fibrosis: A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.

Research Excerpts

ExcerptRelevanceReference
"Collectively, our findings suggest that treatment of pulmonary fibrosis patients with ATRvD1 deserves to be explored as a therapeutic option in the clinical setting."1.91Pleiotropic antifibrotic actions of aspirin-triggered resolvin D1 in the lungs. ( Araújo-Silva, CA; Benjamim, CF; Blanco, PJ; Bulant, CA; Canetti, C; Fraga-Junior, VS; Guilherme, RF; Lemos, FS; Magalhães, NS; Moraes, JA; Nogueira, TO; Pecli, C; Scharfstein, J; Serra, R; Silva, JBNF; Svensjö, E; Waclawiack, I, 2023)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19904 (50.00)18.7374
1990's1 (12.50)18.2507
2000's1 (12.50)29.6817
2010's1 (12.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Guilherme, RF2
Silva, JBNF1
Waclawiack, I1
Fraga-Junior, VS1
Nogueira, TO1
Pecli, C1
Araújo-Silva, CA1
Magalhães, NS1
Lemos, FS1
Bulant, CA1
Blanco, PJ1
Serra, R1
Svensjö, E1
Scharfstein, J1
Moraes, JA1
Canetti, C3
Benjamim, CF3
Xisto, DG1
Kunkel, SL2
Freire-de-Lima, CG1
Rocco, PR1
Neves, JS1
Fierro, IM2
Martins, V1
Valença, SS1
Farias-Filho, FA1
Molinaro, R1
Simões, RL1
Ferreira, TP1
e Silva, PM1
Hogaboam, CM1
SHERIDAN, LA1
HARRISON, EG1
DIVERTIE, MB1
Carrión Valero, F1
Marín Pardo, J1
Meier-Sydow, J1
Mitrou, PS1
Eyre, P1
Nymeyer, DH1
McCraw, BM1
Deline, TR1
Cooper, JA1
Matthay, RA1

Reviews

3 reviews available for aspirin and Pulmonary Fibrosis

ArticleYear
[Pulmonary toxicity caused by drugs].
    Archivos de bronconeumologia, 1999, Volume: 35, Issue:11

    Topics: Acute Disease; Amiodarone; Anti-Arrhythmia Agents; Anti-Infective Agents, Urinary; Anti-Inflammatory

1999
[Treatment of auto-immune diseases with special reference to their pulmonary manifestations (author's transl)].
    Praxis und Klinik der Pneumologie, 1979, Volume: 33 Suppl 1

    Topics: Adrenal Cortex Hormones; Anti-Glomerular Basement Membrane Disease; Anti-Inflammatory Agents; Antine

1979
Drug-induced pulmonary disease.
    Disease-a-month : DM, 1987, Volume: 33, Issue:2

    Topics: Anti-Arrhythmia Agents; Anticonvulsants; Antineoplastic Agents; Aspirin; Gold; Humans; Hydrochloroth

1987

Other Studies

5 other studies available for aspirin and Pulmonary Fibrosis

ArticleYear
Pleiotropic antifibrotic actions of aspirin-triggered resolvin D1 in the lungs.
    Frontiers in immunology, 2023, Volume: 14

    Topics: Aspirin; Bleomycin; Docosahexaenoic Acids; Humans; Lung; Pulmonary Fibrosis; Transforming Growth Fac

2023
Pulmonary antifibrotic mechanisms aspirin-triggered lipoxin A(4) synthetic analog.
    American journal of respiratory cell and molecular biology, 2013, Volume: 49, Issue:6

    Topics: Animals; Arginase; Aspirin; Biomarkers; Bleomycin; Bronchoalveolar Lavage Fluid; Cell Count; Cytokin

2013
ATLa, an aspirin-triggered lipoxin A4 synthetic analog, prevents the inflammatory and fibrotic effects of bleomycin-induced pulmonary fibrosis.
    Journal of immunology (Baltimore, Md. : 1950), 2009, May-01, Volume: 182, Issue:9

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antifibrinolytic Agents; Aspirin; Bleomycin; Immun

2009
THE CURRENT STATUS OF IDIOPATHIC PULMONARY FIBROSIS (HAMMAN-RICH SYNDROME).
    The Medical clinics of North America, 1964, Volume: 48

    Topics: Anti-Bacterial Agents; Aspirin; Biopsy; Child; Diagnosis, Differential; Digitalis Glycosides; Diuret

1964
Protection by acetylsalicylic acid and other agents in experimental acute interstitial pneumonia of calves.
    The Veterinary record, 1976, Jan-24, Volume: 98, Issue:4

    Topics: Animals; Ascariasis; Aspirin; Cattle; Cattle Diseases; Histamine; Lung; Meclofenamic Acid; Methyserg

1976